We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Richter Abandons Female Sexual Dysfunction Treatment Collaboration with Palatin
Richter Abandons Female Sexual Dysfunction Treatment Collaboration with Palatin
Palatin Technologies and its partner Gedeon Richter have terminated their collaboration agreement to develop bremelanotide to treat female sexual dysfunction following last month’s FDA approval of Sprout Pharamceuticals’ Addyi for the same indication.